These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1980641)

  • 21. Syntheses, opioid binding affinities, and potencies of dynorphin A analogues substituted in positions, 1, 6, 7, 8 and 10.
    Kawasaki AM; Knapp RJ; Walton A; Wire WS; Zalewska T; Yamamura HI; Porreca F; Burks TF; Hruby VJ
    Int J Pept Protein Res; 1993 Nov; 42(5):411-9. PubMed ID: 7906258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of highly potent and selective dynorphin A analogues as new medicines.
    Lung FD; Chen CH; Liu JH
    J Pept Res; 2005 Nov; 66(5):263-76. PubMed ID: 16218994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological activity of analogs of dynorphin-A(1-13) substituted in positions 2 and 4: design of [Ala2,Trp4]-Dyn-A(1-13) as a putative selective opioid antagonist.
    Lemaire S; Turcotte A
    Can J Physiol Pharmacol; 1986 Jun; 64(6):673-8. PubMed ID: 2875777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and opioid activity of conformationally constrained dynorphin A analogues. 2. Conformational constraint in the "address" sequence.
    Arttamangkul S; Ishmael JE; Murray TF; Grandy DK; DeLander GE; Kieffer BL; Aldrich JV
    J Med Chem; 1997 Apr; 40(8):1211-8. PubMed ID: 9111295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and opioid activities of [D-Leu-8]Dynorphin(1-8) analogs containing a reduced peptide bond, psi(CH2-NH).
    Ambo A; Adachi T; Sasaki Y
    Chem Pharm Bull (Tokyo); 1995 Sep; 43(9):1547-50. PubMed ID: 7586080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physical dependence liability of dynorphin A analogs in rodents.
    Nakazawa T; Kaneko T; Yoshino H; Tachibana S; Goto M; Taki T; Yamatsu K
    Eur J Pharmacol; 1991 Aug; 201(2-3):185-9. PubMed ID: 1686757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and opioid activity of [D-Pro10]dynorphin A-(1-11) analogues with N-terminal alkyl substitution.
    Choi H; Murray TF; DeLander GE; Schmidt WK; Aldrich JV
    J Med Chem; 1997 Aug; 40(17):2733-9. PubMed ID: 9276018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and opioid activity of dynorphin A-(1-13)NH2 analogues containing cis- and trans-4-aminocyclohexanecarboxylic acid.
    Snyder KR; Murray TF; DeLander GE; Aldrich JV
    J Med Chem; 1993 Jun; 36(13):1921-2. PubMed ID: 8099977
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthesis and biological activities of dynorphin A analogues with opioid antagonist properties.
    Gairin JE; Mazarguil H; Alvinerie P; Saint-Pierre S; Meunier JC; Cros J
    J Med Chem; 1986 Oct; 29(10):1913-7. PubMed ID: 2876099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The choice of opioid receptor subtype in isolated preparations by dynorphins.
    Oka T; Aoki K; Kajiwara M
    Life Sci; 1983; 33 Suppl 1():311-4. PubMed ID: 6141492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [D-Ala2, (F5) Phe4]-dynorphin 1-13-NH2 (DAFPHEDYN): a potent analog of dynorphin 1-13.
    Walker JM; Coy DH; Young EA; Baldrighi G; Siegel SF; Bowen WD; Akil H
    Peptides; 1987; 8(5):811-7. PubMed ID: 2893357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and opioid activity of dynorphin A-(1-13)NH2 analogues containing cis- and trans-4-aminocyclohexanecarboxylic acid.
    Snyder KR; Murray TF; DeLander GE; Aldrich JV
    J Med Chem; 1993 Apr; 36(8):1100-3. PubMed ID: 8097539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynorphin B-29: chemical synthesis and pharmacological properties in opioid systems in vitro.
    Sanchez-Blazquez P; Chang JK; Garzon J; Lee NM
    Neuropeptides; 1984 Sep; 4(5):369-74. PubMed ID: 6149489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analgesic, receptor binding, and peripheral opioid activities of synthetic dermorphin-dynorphin hybrid peptides.
    Ho CL; Ko JL; Hwang LL; Wang KT
    Int J Pept Protein Res; 1990 Feb; 35(2):99-104. PubMed ID: 1969854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioid activity of dermenkephalin analogues in the guinea-pig myenteric plexus and the hamster vas deferens.
    Sagan S; Corbett AD; Amiche M; Delfour A; Nicolas P; Kosterlitz HW
    Br J Pharmacol; 1991 Oct; 104(2):428-32. PubMed ID: 1665735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biocytin13]dynorphin A 1-13 amide: a potential probe for the kappa-opioid receptor.
    Hochhaus G; Patthy A; Schwietert R; Santi DV; Sadée W
    Pharm Res; 1988 Dec; 5(12):790-4. PubMed ID: 2907785
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Irreversible blockade of the kappa-receptor by a newly synthesized dynorphin derivative containing a 3-nitro-2-pyridinesulfenyl group.
    Koike K; Takayanagi I; Hirakura Y; Matsueda R
    Arch Int Pharmacodyn Ther; 1991; 313():33-46. PubMed ID: 1687773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynorphin A-(1-13)-Tyr14-Leu15-Phe16-Asn17-Gly18-Pro19 : a potent and selective kappa opioid peptide.
    Martinka GP; Jhamandas K; Sabourin L; Lapierre C; Lemaire S
    Eur J Pharmacol; 1991 Apr; 196(2):161-7. PubMed ID: 1678718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Receptor preference of dynorphin A fragments in the mouse vas deferens determined by different techniques.
    Schulz R; Wüster M; Herz A
    J Pharmacol Exp Ther; 1984 Jul; 230(1):200-4. PubMed ID: 6146706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis using a Fmoc-based strategy and biological activities of some reduced peptide bond pseudopeptide analogues of dynorphin A1.
    Meyer JP; Davis P; Lee KB; Porreca F; Yamamura HI; Hruby VJ
    J Med Chem; 1995 Sep; 38(18):3462-8. PubMed ID: 7658433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.